Characterization of the murine p19(ARF) promoter CpG island and its methylation pattern in primary lymphomas

Carcinogenesis

Volumn 21, Issue 4, 2000, Pages 817-821

  Meléndez, Bárbara ^a   Malumbres, Marcos ^b,c   Pérez De Castro, Ignacio ^d   Santos, Javier ^a   Pellicer, Angel ^d   Fernández Piqueras, José ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b Invest Oncol Carlos III Ctr Nac   (Spain)

^c CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^d NEW YORK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEIC ACID BINDING PROTEIN; PROTEIN P16; PROTEIN P19; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CYCLE; CONTROLLED STUDY; DNA METHYLATION; GENE MAPPING; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RETINOBLASTOMA; T CELL LYMPHOMA; TRANSCRIPTION REGULATION;

EID: 0343012076     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/21.4.817     Document Type: Article

References (40)

1. Sherr, C.J. (1998) Tumor surveillance via the ARF-p53 pathway. Genes Dev., 12, 2984-2991.
2. Chin, L., Pomerantz, J. and DePinho, R.A. (1998) The INK4a/ARF tumor suppresor: one gene-two products-two pathways. Trends Biochem. Sci., 23, 291-296.
3. Sharpless, N.E. and DePinho, R.A. (1999) The INK4A/ARF locus and its two gene products. Curr. Opin. Genet. Dev., 9, 22-30.
4. Kamijo, T., Weber, J.D., Zambetti, G., Zyndy, F., Roussel, M.F. and Sherr, C.J. (1998) Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2. Proc. Natl Acad. Sci. USA, 95, 8292-8297.
5. Pomerantz, J., Schreiber-Agus, N., Liegeois, N.J., Silverman, A., Alland, L., Chin, L., Potes, J., Chen, K., Orlow, I., Lee, H.-W., Cordon-Cardo, C. and DePinho, R.A. (1998) The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell, 92, 713-723.
6. Stott, F.J., Bates, S., James, M.C., McConnell, B.B., Starborg, M., Brookes, S., Palmero, I., Ryan, K., Hara, E., Vousden, K.H. and Peters, G. (1998) The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2. EMBO J., 17, 5001-5014.
7. Zhang, Y., Xiong, Y. and Yarbrough, W.G. (1998) ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell, 92, 725-734.
8. Weber, J.D., Taylor, L.J., Roussel, M.F., Sherr, C.J. and Bar-Sagi, D. (1999) Nucleolar Arf sequesters Mdm2 and activates p53. Nature Cell Biol., 1, 20-26.
9. Tao, W. and Levine, A.J. (1999) P19(ARF) stabilizes p53 by blocking nucleo-cytoplasmic shuttling of Mdm2. Proc. Natl Acad. Sci. USA, 96, 6937-6941.
10. Zhang, Y. and Xiong, Y. (1999) Mutations in human ARF exor 2 disrupt its nucleolar localization and impair its ability to block nuclear export of MDM2 and p53. Mol. Cell, 3, 579-591.
11. CDKN2 expression and its implications for cell immortalization and senescence. Mol. Cell. Biol., 16, 859-867.
12. INK4a. Cell, 88, 593-602.
13. Huschtscha, L.I. and Reddel, R.R. (1999) p16(INK4a) and the control of cellular proliferative life span. Carcinogenesis, 20, 921-926.
14. Gonzalez-Zulueta, M., Bender, C.M., Yang, A.S., Nguyen, T.-D., Beart, R.W., VanTornout, J.M. and Jones, P.A. (1995) Methylation of the CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res., 55, 4531-4535.
15. Herman, J.G., Merlo, A., Mao, L., Lapidus, R.G., Issa, J.P., Davidson, N.E., Sidransky, D. and Baylin, S.B. (1995) Inactivation of the CDKN2/p16/ MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res., 55, 4525-4530.
16. Merlo, A., Herman, J.G., Mao, L., Lee, D.J., Gabrielson, E., Burger, P.C., Baylin, S.B. and Sidransky, D. (1995) 5′ CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MTS1 in human cancers. Nature Med., 1, 686-692.
17. INK4a/CDKN2A tumor suppressor and its relatives. Biochim. Biophys. Acta, 1378, F115-F177.
18. Zindy, F., Eischen, C.M., Randle, D.H., Kamijo, T., Cleveland, J.L., Sherr, C.J. and Roussel, M.F. (1998) Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev., 12, 2424-2433.
19. ARF links the tumour suppressors RB and p53. Nature, 395, 124-125.
20. Stanchina, E., McCurrach, M.E., Zindy, F., Shieh, S.-Y., Ferbeyre, G., Samuelson, A.V., Prives, C., Roussel, M.F., Sherr, C.J. and Lowe, S.W. (1998) E1A signaling to p53 involves the p19ARF tumor suppressor. Genes Dev., 12, 2434-2442.
21. Robertson, K.D. and Jones, P.A. (1998) The human ARF cell cycle regulatory gene promoter is a CpG island which can be silenced by DNA methylation and down-regulated by wild-type p53. Mol. Cell. Biol., 18, 6457-6473.
22. Palmero, I., Pantoja, C. and Serrano, M. (1998) p19ARF links the tumour suppressor p53 to Ras. Nature, 395, 125-126.
23. Inoue, K., Roussel, M.F. and Sherr, C.J. (1999) Induction of ARF tumor suppressor gene expression and cell cycle arrest by transcription factor DMP1. Proc. Natl Acad. Sci. USA, 96, 3993-3998.
24. INK4a alterations in murine primary T-cell lymphomas. Oncogene, 14, 1361-1370.
25. Quelle, D.E., Zindy, F., Ashmun, R.A. and Sherr, C.J. (1995) Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell, 83, 993-1000.
26. Gardiner-Garden, M. and Frommer, M. (1987) CpG islands in vertebrate genomes. J. Mol. Biol., 196, 261-282.
27. Antequera, F. and Bird, A. (1993) In Jost, J.P. and Saluz, H.P. (eds) DNA Methylation: Molecular Biology and Biological Significance. Birkhäuser Verlag, Basel, Switzerland, pp. 169-185.
28. Macleod, D., Charlton, J., Mullins, J. and Bird, A.P. (1994) Sp1 sites in the mouse Aprt gene promoter are required to prevent methylation of the CpG island. Genes Dev., 8, 2282-2292.
29. Guerrero, I. and Pellicer, A. (1987) Mutational activation of oncogenes in animal model systems of carcinogenesis. Mutat. Res., 18, 293-308.
30. Santos, J., Pérez de Castro, I., Herranz, M., Pellicer, A. and Fernández-Piqueras, J. (1996) Allelic losses on chromosome 4 suggest the existence of a candidate tumor suppressor gene region of about 0.6 cM in γ-radiation-induced mouse primary thymic lymphomas. Oncogene, 12, 669-676.
31. Herzog, C.R., Soloff, E.V., McDoniels, A.L., Tyson, F.L., Malkinson, A.M., Haugen-Strano, A., Wiseman, R.W., Anderson, M.W. and You, M. (1996) Homozygous codeletion and differential decreased expression of p15INK4b, p16INK4a-α and p16INK4a-β in mouse lung tumor cells. Oncogene, 13, 1885-1891.
32. Baylin, S.B., Herman, J.G., Graff, J.R., Vertino, P.M. and Issa, J.P. (1998) Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv. Cancer Res., 72, 141-196.
33. INK4b 3′-untranslated region interferes with its transcriptional regulation in primary lymphomas. Oncogene, 18, 385-396.
34. 15INK4b genes in 2′,3′-dideoxycytidine- and 1,3-butadiene-induced murine lymphomas. Oncogene, 16, 803-808.
35. Mummaneni, P., Yates, P., Simpson, J., Rose, J. and Turker, M.S. (1998) The primary function of a redundant Sp1 binding site in the mouse aprt gene promoter is to block epigenetic gene inactivation. Nucleic Acids Res., 26, 5163-5169.
36. Siegfried, Z., Eden, S., Mendelsohn, M., Feng, X., Tsuberi, B.Z. and Cedar, H. (1999) DNA methylation represses transcription in vivo. Nature Genet., 12, 203-206.
37. ARF. Cell, 91, 649-659.
38. Brathwaite, O., Bayona, W. and Newcomb, E.W. (1992) p53 mutations in C57BL/6J murine thymic lymphomas induced by gamma-irradiation and N-methylnitrosourea. Cancer Res., 52, 3791-3795.
39. Pérez de Castro, I., Malumbres, M. Santos, J., Pellicer, A. and Fernández-Piqueras, J. (1999) Cooperative alterations of Rb pathway regulators in mouse primary T cell lymphomas. Carcinogenesis, 20, 1675-1682.
40. Baur, A.S., Shaw, P., Burri, N., Delacretaz, F., Bosman, F.T. and Chaubert, P. (1999) Frequent methylation silencing of p15/INK4b (MTS2) and p16/INK4a (MTS1) in B-cell and T-cell lymphomas. Blood, 94, 1773-1781.